Roche Diagnostics to Invest $310 Million in China

Did you know?

ChinaBio^® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…

More white papers:

>>China Partnering 2012: Driving Future Innovation

>>China Life Science 2012: From Local to Global

Free Content

Week in Review

In My Opinion

Free Articles

Education Center

Interfax-BW Releases

Subscriber Content

Roche Diagnostics to Invest $310 Million in China

publication date: Jun 1, 2012

Roche Diagnostics is planning to spend $310 million in China over the next few years to build up its sales, adding offices in nine cities across China. The company will also invest in “personnel development, recruitment, instruments and systems,” according to Roche Diagnostic’s COO, Daniel O’Day. Roche Diagnostics wants China to be its second largest market, up from fifth currently. More details....

Stock Symbol: (VX: ROG)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Click here to join.